Navigation Links
Odyssey Thera Announces Achievement of Pfizer Drug Candidate Milestones
Date:10/7/2009

SAN RAMON, Calif., Oct. 7 /PRNewswire/ -- Odyssey Thera, Inc. announced that it will receive milestone payments from one of its investors, Pfizer Inc. following Pfizer's decision to progress drug candidates studied by Odyssey Thera as part of Odyssey's multi-year alliance with Pfizer announced in August, 2006. These milestones are the Company's fourth and fifth to be earned for the advancement of specific drug candidates, and follow other technology development milestones previously achieved in the alliance.

"We are delighted to participate in the success of Pfizer's cutting-edge drug discovery programs," said John K. Westwick, Ph.D., Odyssey Thera's President and CEO. "We look forward to continued success in the application of our validated strategies, both in our partnerships and for our internal drug development programs."

About Odyssey Thera, Inc.

Odyssey Thera's patented technology measures disease-relevant pathway activity within living human cells. Odyssey is leveraging its proprietary drug discovery and development platform for internal programs and for premier pharmaceutical and biotechnology company partners.

To learn more about Odyssey Thera, please visit www.odysseythera.com.

SOURCE Odyssey Thera, Inc.


'/>"/>
SOURCE Odyssey Thera, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Physiotherapy Associates Marks National Physical Therapy Month With Free Educational Brochure
2. Acne Scars Significantly Improved by a Combination Treatment of Photodynamic Therapy and Percutaneous Collagen Induction
3. URAC Introduces New Performance Measures and Reporting Standards for Pharmacy Benefit Management and Drug Therapy Management Accreditation
4. Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp.
5. Ocular Therapeutix, Inc. Appoints Two New Board Members
6. Solace Therapeutics, Inc. Announces CE Mark Approval
7. Cortheras Relaxin Receives FDA Fast Track Designation for the Treatment of Acute Heart Failure
8. Echo Therapeutics to Present at 4th Annual JMP Securities Healthcare Conference
9. EMD Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United States
10. Article Published in Expert Opinion on Biological Therapy Evaluates StemEx(R) (carlecortemcel-l) for Leukemia and Lymphoma
11. InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2017)... Israel , Aug. 15, 2017 /PRNewswire/ ... of adult stem cell technologies for neurodegenerative diseases, announced ... 2017. "We are ... Phase 3 trial to investigate NurOwn ® in ... Executive Officer of BrainStorm. "We have agreements with Mass. ...
(Date:8/7/2017)... Md. , Aug. 7, 2017 ... healthcare member acquisition, retention, and engagement, announced the ... of Strategy and Product Development, effective as of ... consulting and technology implementation strategy for our clients. ... of experience in consulting and business analytics within ...
(Date:8/4/2017)... ROCKVILLE, Md. , Aug. 4, 2017 ... during or shortly after a physician/patient consult has long ... industry, and was a notable focus of the largest ...  This is according to healthcare market research firm Kalorama ... of care testing (POCT) offerings or related supplies and ...
Breaking Medicine Technology:
(Date:8/21/2017)... Beach, California (PRWEB) , ... August 21, 2017 , ... ... raise money and awareness for Alzheimer’s Family Center. , Guests will be able ... from Newport Beach Plaza, Braised Lamb Shank with Fennel Dill Salad, Feta Cheese Sauce ...
(Date:8/21/2017)... PITTSBURGH, PA (PRWEB) , ... August 21, 2017 , ... ... Allegheny Health Network (AHN), a Highmark Health company, to its Board of Trustees ... is a not-for-profit association of health care provider organizations and individuals that are committed ...
(Date:8/20/2017)... ... 20, 2017 , ... HIPAA Solutions, LC is ... assisted multiple clients in successfully passing audits such as Office of Civil Rights ... SOC Level 2), and State Data Use Agreement Audits. , HIPAA Solutions, ...
(Date:8/19/2017)... ... 18, 2017 , ... Paragon and IOTA ... help the cannabis industry move towards greater legitimacy. By incorporating IOTA’s unique approach ... with lower fees. Paragon will build a fully verifiable database to track prescriptions, ...
(Date:8/19/2017)... ... August 19, 2017 , ... Yesterday, the President of the United States ... two sides. There are not two sides to hatred, bigotry, discrimination, and a white ... and the NPEIV stands against all forms of such hatred and discrimination in this ...
Breaking Medicine News(10 mins):